Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation
about
Brain Gαi 2 -subunit proteins and the prevention of salt sensitive hypertensionRenal AfferentsNeurogenic and sympathoexcitatory actions of NaCl in hypertension.Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systemsSympathetic stimulation of thiazide-sensitive sodium chloride cotransport in the generation of salt-sensitive hypertension.Renal sodium handling and sodium sensitivityNeural programming of mesenteric and renal arteries.Gαi2-protein-mediated signal transduction: central nervous system molecular mechanism countering the development of sodium-dependent hypertension.A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin.Direct conscious telemetry recordings demonstrate increased renal sympathetic nerve activity in rats with chronic kidney diseaseThe stress of maternal separation causes misprogramming in the postnatal maturation of rat resistance arteries.Differential role of afferent and efferent renal nerves in the maintenance of early- and late-phase Dahl S hypertension.Where hypertension happens.Revelations about carotid body function through its pathological role in resistant hypertensionAltered Differential Control of Sympathetic Outflow Following Sedentary Conditions: Role of Subregional Neuroplasticity in the RVLMBilateral Renal Denervation Ameliorates Isoproterenol-Induced Heart Failure through Downregulation of the Brain Renin-Angiotensin System and Inflammation in RatDissecting the genetic components of a quantitative trait locus for blood pressure and renal pathology on rat chromosome 3.Organ selective regulation of sympathetic outflow by the brain Angiotensin system.Invasive treatment of resistant hypertension: present and future.Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-associated pathways.Impact of renal denervation on tissue Na(+) content in treatment-resistant hypertension.Role of the kidney in the pathogenesis of hypertension: time for a neo-Guytonian paradigm or a paradigm shift?Blood Pressure: Return of the Sympathetics?Renal Nerves and Long-Term Control of Arterial Pressure.Differential Distribution of Renal Nerves in the Sympathetic Ganglia of the Rat.Maternal Gestational Hypertension-Induced Sensitization of Angiotensin II Hypertension Is Reversed by Renal Denervation or Angiotensin-Converting Enzyme Inhibition in Rat Offspring.Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats.Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy: Lost, and Then Found, in Translation.Role of afferent and efferent renal nerves in the development of AngII-salt hypertension in rats.The effect of renal denervation on resistant hypertension: Meta-analysis of randomized controlled clinical trials.Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with β-receptor blockade.Erythrocyte Salt Sedimentation Assay Does Not Predict Response to Renal Denervation.Measurement of cations, anions, and acetate in serum, urine, cerebrospinal fluid, and tissue by ion chromatography.Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
P2860
Q26782874-C4B80EEE-AB91-4641-9DE7-77366C53E31DQ28069624-E33F234B-8DC7-4A07-9954-37E088B425E1Q33598143-8E13567F-7770-4257-B07D-75D5F0565F92Q33660709-00B57A18-6698-4128-9471-ED08CC826D22Q33770703-8773D15B-DE39-4BC5-B533-0A0FCB43ADF0Q33853484-F0757FB6-E3FE-480E-A51C-29EF4AB34CFAQ34062825-87AFCAFA-B572-416F-9B61-A76C12504D84Q34714621-189175A8-B501-4C13-9CB7-586E18B26B3CQ34980701-0E352F14-B051-44E9-AC78-392E8F6DD090Q35912934-41E8BEBA-1345-4E43-9229-137AF13EAFE5Q36339435-47D64BB8-B4C4-49C1-A337-DB99F8AD7B58Q36699859-2008F163-CD0C-4EE3-96CE-62A4FC2E16A9Q36793516-B731863D-91E9-475E-987B-1F6C5939E4D7Q37015249-EA6B3168-1BFD-4C15-9425-52A42D0B7C07Q37104554-C386A5A5-DCCB-4BC1-B830-56FCE68CD9E0Q37323702-B2EAC4CE-8EFD-4D56-8727-4CB9145C0404Q37558426-EBAE32C0-A475-4ACF-A70C-BE281A3502AAQ38107424-7556D3B5-78A6-4131-8CDB-1EFC20957B5EQ38245560-7DAF8817-C752-4FFA-9985-54BD9FBEB648Q38292348-D3143BEE-F40C-4866-A275-28C67FB9DB65Q38606139-D97EE36A-D339-422A-97EC-EAE3197359DDQ38638096-39E2EF59-CD29-4C12-AF49-F958D28D4CC5Q38689776-9B11FDAE-C276-465E-829F-719237CFF1C1Q38741056-986F52EB-B97B-4399-8773-B9958C5A9F37Q48187754-0CEEF854-9FD2-495F-BCBF-108C9E8ED2E9Q48298434-588C1A06-CA32-48E1-9E93-41F35FB21828Q48983840-FAB1350E-595F-407E-8A1A-A9510BDD6D34Q49359607-4403AD8B-D896-4CDA-8042-BC970EBB4ED5Q50188443-A01E01CC-BD1A-42B4-B3A3-59B67961143FQ50866344-8CD58D31-B468-43C2-A929-0E9F6A0D1FA5Q50991341-B806E56E-CCC0-4353-A9D3-7499BB2F4372Q53652278-EDB8C3C0-C637-4AE0-BFCF-604153F61BC9Q55025843-F1D73E5A-6891-4190-AA36-81595D073687Q55261980-B76FBC2E-B28F-4F55-B86B-50435717F236Q55374393-5C4CA82B-D3F5-4728-A7DE-BA6C596F9BB0
P2860
Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation
@en
type
label
Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation
@en
prefLabel
Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation
@en
P2093
P2860
P1433
P1476
Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation
@en
P2093
Gregory D Fink
Jason D Foss
John W Osborn
P2860
P304
P356
10.1161/HYPERTENSIONAHA.111.00474
P407
P577
2013-02-04T00:00:00Z